News
Viva in Vitro amplía su equipo científico atrayendo talento expatriado
Viva in Vitro amplía su equipo científico atrayendo talento expatriado
La biotech Viva in Vitro alcanza los 1,2 millones de euros de inversión para prevenir la sepsis en hospitales de todo el mundo
Surgida como spinoff del Instituto Murciano de Investigación Biosanitaria (IMIB), abre así una nueva etapa en la que se ampliará el equipo
Viva In Vitro receives the Impact Business 2023 recognition as a social and environmental impact initiative.
The Ship2B Foundation has communicated to the biomedical company Viva In Vitro on this February 15.— “After going through
Noticia en Expansión ‘Start up’ que pasan del laboratorio a la empresa
Viva in Vitro, ‘spin off’ del Hospital Clínico Universitario Virgen de la Arrixaca, la Universidad de Murcia y el instituto
Joaquín Gómez Moya: “When innovation is based on science, it is more likely to bring benefits to society”
Viva In Vitro Diagnostics CEO considers it essential to create an association of biotechnology companies in the Region.
Hi!
Welcome to our news page. After years of work and dedication to give this project a corporate shape, Pablo Pelegrín,
Dr. Pablo Pelegrín received INFO’s recognition for his contribution to the Knowledge Economy
During the Somos Equipo event, regional president Fernando López-Miras recognized the leaders of the regional economic transformation towards a Knowledge
